Inhibitory effect of fluvastatin on lysophosphatidylcholine-induced nonselective cation current in guinea pig ventricular myocytes

Molecular Pharmacology

Volumn 62, Issue 3, 2002, Pages 602-607

  Li, Libing ^a   Matsuoka, Isao ^a   Suzuki, Yuichi ^a   Watanabe, Yasuhide ^a   Ishibashi, Toshiyuki ^a   Yokoyama, Keiko ^a   Maruyama, Yukio ^a   Kimura, Junko ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; BOTULINUM TOXIN; CATION; EXOENZYME C3; FLUINDOSTATIN; GERANYLGERANYL PYROPHOSPHATE; GUANINE NUCLEOTIDE BINDING PROTEIN; LYSOPHOSPHATIDYLCHOLINE; MEVALONIC ACID; PERTUSSIS TOXIN; PHOSPHOTRANSFERASE INHIBITOR; RECEPTOR SUBTYPE; RHO FACTOR; RHO KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG EFFECT; GUINEA PIG; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE WALL; ION CURRENT; MEMBRANE CURRENT; METABOLITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VOLTAGE CLAMP;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTIOXIDANTS; BOTULINUM TOXINS; CATIONS; DRUG INTERACTIONS; ENZYME INHIBITORS; FATTY ACIDS, MONOUNSATURATED; GUINEA PIGS; HEART VENTRICLES; INDOLES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ION CHANNELS; LYSOPHOSPHATIDYLCHOLINES; MEMBRANE POTENTIALS; MEVALONIC ACID; MYOCARDIUM; PERTUSSIS TOXIN; POLYISOPRENYL PHOSPHATES; PROTEIN-SERINE-THREONINE KINASES; VIRULENCE FACTORS, BORDETELLA;

EID: 0036765586     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.3.602     Document Type: Article

References (31)

1. + current in guinea-pig atrial myocytes by sphingosine-1-phosphate. J Physiol 489:701-777.
2. Corr PB, Snyder DW, Lee BI, Gross RW, Keim C, and Sobel B (1982) Pathophysiological concentrations of lysophosphatides and the slow response. Am J Physiol 243:H187-H195.
3. Corsini A, Bellosta S, Baetta R, Fumagalli R, Paoletti R, and Bernini F (1999) New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther 84:413-428.
4. Fukushima N, Ishii I, Contos JJ, Weiner JA, and Chun J (2001) Lysophospholipid receptors. Annu Rev Pharmacol Toxicol 41:507-534.
5. Glomset JA, Gelb MH, and Farnsworh CC (1990) Prenyl proteins in eukaryotic cells: a new type of membrane anchor. Trends Biochem Sci 15:139-142.
6. Goldstein JL and Brown MS (1990) Regulation of the mevalonate pathway. Nature (Lond) 349:425-430.
7. Hashizume H and Abiko Y (1996) Dilazep and d-propranolol attenuate calcium overload induced by lysophosphatidylcholine in cardiac myocytes. Clin Exp Cardiol 24:977-988.
8. Hashizume H, Chen M, Ma H, Hoque N, Hara A, Yazawa K, Akahara M, Xiao C-Y, and Abiko Y (1998) Lysophosphatidylcholine: A possible modulator, in Protection against Ischemia/Reperfusion Damage of the Heart (Abiko Y, Karmazyn M eds), pp 75-87, Tokyo, Springer-Verlag.
9. Hoque ANE, Hoque N, Hashizume H, and Abiko Y (1995) A study on dilazep: II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart. Jpn J Pharmacol 67:233-241.
10. Isenberg G and Klöckner U (1982) Calcium tolerant ventricular mgocytes prepared by preincubation in a "KB medium". Pfleug Arch Eur J Pbysiol 395:6-18.
11. + channels in cell-free membrane of atrial cells. Am J Physiol 251:H681-H684.
12. Kaberowski JHS, Zhu K, Le LQ, Witte ON, and Xu Y (2001) Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A Science (Wash DC) 293:702-705.
13. Laufs U and Liao JK (1998) Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273:24266-24271.
14. Liliom K, Sun G, Bünemann M, Virág T, Nusser N, Baker DL, Wang D, Fabian MJ, Brandts B, Bender K, et al. (2001) Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptars. Biochem J 355:189-197.
15. Magishi K, Kimura J, Kubo Y, and Abiko Y (1996) Exogenous lysophosphatidylcholine increases non-selective cation current in guinea-pig ventricular myocytes. Pfleug Arch Eur J Physiol 432:345-350.
16. Maltese WA (1990) Post-translational modification of proteins by isoprenoids in mammalian cells. FASEB J 4:3319-3328.
17. Muraki K and Imaizumi Y (2001) A novel action o f sphingosine-1-phosphate to activate a non-selective cation channel in human endothelial cell. J Physiol 537:431-441.
18. Otani H, Prasad MR, Jones RM, and Das DK (1989) Mechanism of membrane phospholipid degradation in ischemic-reperfused rat hearts. Am J Physiol 257: H252-H258.
19. Ridley AJ and Hall A (1992) The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389-399.
20. Sah VP, Seasholtz TM, Sagi SA, and Brown JH (2000) The role of Rho in G protein-coupled receptor signal tranzduction. Annu Rev Pharmacol Toxicol 40: 459-489.
21. 2+ accumulation in rat cardiac myocytes. Am J Physiol 244:H32-H38.
22. Sedlis SP, Sequeira JM, and Altszuler HM (1990) Coronary sinus lysophosphatidyl choline accumulation during rapid atrial pacing. Am J Cardiol 66:695-698.
23. Shaikh NA and Downer E (1981) Time course of changes in porcine myocardial phospholipid levels during ischemia. Circ Res 49:316-325.
24. Sobel BE, Corr PB, Robison AK, Goldstein RA, Witkowski FX, and Klein MS (1978) Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. J Clin Invest 62:546-553.
25. Uehata M, Ishizaki T, Satoh H, One T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Mackawa M, et al. (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature (Lond) 399:990-994.
26. 2+-overload in isolated cardiomyocytes and effect of cytoprotective drugs. J Mol Cell Cardiol 24:977-988.
27. 2+ exchange current in guinea-pig cardiac ventricular cells. Br J Pharmacol 119:555-563.
28. Woodley SL, Ikenouchi H, and Barry WH (1991) Lysophosphatidylcholine increases cytosolic calcium in ventricular myocytes by direct action on the sarcolemma. J Mol Cell Cardiol 23:67-80.
29. Yazawa K, Kaibara M, Ohara M, and Kameyama M (1990) An improved method or isolating cardiac myocytes useful for patch-clamp studies. Jpn J Physiol 40:157-163.
30. Yokoyama K, Ishibashi T, Ohkawara H, Kimura J, Matsuoka I, Sakamoto T, Nagata K, Sugimoto K, Sakurada S, and Maruyama Y (2002) HMG-CoA reductase inhibitors suppress intraellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells. Circulation 105: 962-967.
31. Zhu K, Baudhuin LM, Hong G, Williams FS, Cristina KL, Kabarowski JHS, Witte ON, and Xu Y (2001) Sphingosylphozphorylcholine and Lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J Biol Chem 276:41335-41335.